Nano-Diamino-Tetrac (NDAT) Enhances Resveratrol-Induced Antiproliferation by Action on the RRM2 Pathway in Colorectal Cancers

Thyroxine inhibits resveratrol-caused apoptosis by PD-L1 in ovarian cancer cells

(2018) Yu-Tang Chin et al.   ENDOCRINE-RELATED CANCER

Tetrac downregulates β-catenin and HMGA2 to promote the effect of resveratrol in colon cancer

(2017) André Wendindondé Nana et al.   ENDOCRINE-RELATED CANCER

Nanoparticulate Tetrac Inhibits Growth and Vascularity of Glioblastoma Xenografts

(2017) Thangirala Sudha et al.   Hormones & Cancer

Actions of l -thyroxine and Nano-diamino-tetrac (Nanotetrac) on PD-L1 in cancer cells

(2016) Hung-Yun Lin et al.   STEROIDS

The combination of tetraiodothyroacetic acid and cetuximab inhibits cell proliferation in colorectal cancers with different K-ras status

(2016) Yee-Shin Lee et al.   STEROIDS

Ribonucleotide reductase is an effective target to overcome gemcitabine resistance in gemcitabine-resistant pancreatic cancer cells with dual resistant factors

(2015) Kentaro Minami et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

Prognostic and therapeutic significance of ribonucleotide reductase small subunit M2 in estrogen-negative breast cancers

(2014) Hang Zhang et al.   BMC CANCER

Nanotetrac targets integrin αvβ3 on tumor cells to disorder cell defense pathways and block angiogenesis

(2014) Paul Davis et al.   OncoTargets and Therapy

Drug Resistance in Cancer: An Overview

(2014) Genevieve Housman et al.   Cancers

AKT-Induced Tamoxifen Resistance Is Overturned by RRM2 Inhibition

(2013) Khyati N. Shah et al.   MOLECULAR CANCER RESEARCH

Tetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer

(2013) Dhruba J Bharali et al.   Nanomedicine

Small Molecule Hormone or Hormone-Like Ligands of Integrin αVβ3: Implications for Cancer Cell Behavior

(2013) Paul J. Davis et al.   Hormones & Cancer

Ribonucleotide reductase small subunit M2 serves as a prognostic biomarker and predicts poor survival of colorectal cancers

(2012) Xiyong Liu et al.   CLINICAL SCIENCE

Comprehensive molecular characterization of human colon and rectal cancer

(2012)   NATURE

Resveratrol induces MMP-9 and cell migration via the p38 kinase and PI-3K pathways in HT1080 human fibrosarcoma cells

(2012) EUN JEONG GWEON et al.   ONCOLOGY REPORTS

Resveratrol and apoptosis

(2011) Hung-Yun Lin et al.   Annals of the New York Academy of Sciences

Ribonucleotide reductase M2 subunit is a novel diagnostic marker and a potential therapeutic target in bladder cancer

(2010) Teppei Morikawa et al.   HISTOPATHOLOGY

Expression of ribonucleotide reductase M2 subunit in gastric cancer and effects of RRM2 inhibition in vitro

(2010) Teppei Morikawa et al.   HUMAN PATHOLOGY

Ribonucleotide reductase small subunit p53R2 promotes oral cancer invasion via the E-cadherin/β-catenin pathway

(2008) Souichi Yanamoto et al.   ORAL ONCOLOGY

Metabolic Effects of Thyroid Hormone Derivatives

(2008) Maria Moreno et al.   THYROID